Description
A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY
€2.42
A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY
Reviews
There are no reviews yet.